Search research articles
Contact Us
Filters
Showing results (141-150 of 177) with videos related to
Page
of 18
Sort By:
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
November 10, 2016
Blood Brain Barrier Impairment in HIV-Positive Naïve and Effectively Treated Patients: Immune Activation Versus Astrocytosis
A Calcagno, A Romito, C Atzori, et al.
Lancet (London, England)
|
December 23, 1989
Nosocomial epidemic of active tuberculosis among HIV-infected patients
G Di Perri, M Cruciani, M C Danzi, et al.
International Journal of Antimicrobial Agents
|
January 29, 2020
Serum Trimethylamine-N-oxide Concentrations in People Living with HIV and the Effect of Probiotic Supplementation
C Montrucchio, A De Nicolò, G D'Ettorre, et al.
The Journal of Antimicrobial Chemotherapy
|
March 24, 2017
Therapeutic drug monitoring of boosted PIs in HIV-positive patients: undetectable plasma concentrations and risk of virological failure
A Calcagno, N Pagani, A Ariaudo, et al.
British Journal of Clinical Pharmacology
|
February 15, 2018
Cerebrospinal fluid abacavir concentrations in HIV-positive patients following once-daily administration
A Calcagno, C Pinnetti, A De Nicolò, et al.
International Journal of Antimicrobial Agents
|
August 13, 2016
Effective treatment of hepatitis C virus infection with sofosbuvir and daclatasvir 90 mg in a patient with severe epilepsy on oxcarbazepine
E J Smolders, C T M M de Kanter, N van 't Veer, et al.
The Pharmacogenomics Journal
|
November 9, 2018
Tenofovir disoproxil fumarate discontinuation for renal outcomes: any room for treatment personalization?
A Calcagno, M Fiumanò, D Zugna, et al.
Journal of Neurovirology
|
July 7, 2017
Detectable cerebrospinal fluid JCV DNA in late-presenting HIV-positive patients: beyond progressive multifocal leukoencephalopathy?
S Mornese Pinna, E Scarvaglieri, M G Milia, et al.
Virology Journal
|
June 13, 2023
Transient plasma viral rebound after SARS-CoV-2 vaccination in an exceptional HIV-1 elite controller woman
L Di Girolamo, M Ferrara, G Trevisan, et al.
The Journal of Antimicrobial Chemotherapy
|
January 11, 2007
Antiretroviral activity of pegylated interferon alfa-2a in patients co-infected with HIV/hepatitis C virus
D Aguilar Marucco, L Veronese, D Gonzalez de Requena, et al.
Page
of 18
Search research articles
Search
Showing results (141-150 of 177) with videos related to
Sort By:
Page
of 18
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
November 10, 2016
Blood Brain Barrier Impairment in HIV-Positive Naïve and Effectively Treated Patients: Immune Activation Versus Astrocytosis
A Calcagno, A Romito, C Atzori, et al.
Lancet (London, England)
|
December 23, 1989
Nosocomial epidemic of active tuberculosis among HIV-infected patients
G Di Perri, M Cruciani, M C Danzi, et al.
International Journal of Antimicrobial Agents
|
January 29, 2020
Serum Trimethylamine-N-oxide Concentrations in People Living with HIV and the Effect of Probiotic Supplementation
C Montrucchio, A De Nicolò, G D'Ettorre, et al.
The Journal of Antimicrobial Chemotherapy
|
March 24, 2017
Therapeutic drug monitoring of boosted PIs in HIV-positive patients: undetectable plasma concentrations and risk of virological failure
A Calcagno, N Pagani, A Ariaudo, et al.
British Journal of Clinical Pharmacology
|
February 15, 2018
Cerebrospinal fluid abacavir concentrations in HIV-positive patients following once-daily administration
A Calcagno, C Pinnetti, A De Nicolò, et al.
International Journal of Antimicrobial Agents
|
August 13, 2016
Effective treatment of hepatitis C virus infection with sofosbuvir and daclatasvir 90 mg in a patient with severe epilepsy on oxcarbazepine
E J Smolders, C T M M de Kanter, N van 't Veer, et al.
The Pharmacogenomics Journal
|
November 9, 2018
Tenofovir disoproxil fumarate discontinuation for renal outcomes: any room for treatment personalization?
A Calcagno, M Fiumanò, D Zugna, et al.
Journal of Neurovirology
|
July 7, 2017
Detectable cerebrospinal fluid JCV DNA in late-presenting HIV-positive patients: beyond progressive multifocal leukoencephalopathy?
S Mornese Pinna, E Scarvaglieri, M G Milia, et al.
Virology Journal
|
June 13, 2023
Transient plasma viral rebound after SARS-CoV-2 vaccination in an exceptional HIV-1 elite controller woman
L Di Girolamo, M Ferrara, G Trevisan, et al.
The Journal of Antimicrobial Chemotherapy
|
January 11, 2007
Antiretroviral activity of pegylated interferon alfa-2a in patients co-infected with HIV/hepatitis C virus
D Aguilar Marucco, L Veronese, D Gonzalez de Requena, et al.
Page
of 18